LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost radiation therapy for head and neck cancer
Disease control Recruiting nowThis early-phase trial tests whether adding the experimental drug ipatasertib to standard chemotherapy and radiation is safe for people with advanced head and neck cancer. Ipatasertib may help stop cancer cells from growing. About 46 adults with certain types of head and neck can…
Matched conditions: LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New drug combo aims to beat throat cancer without removing the voice box
Disease control Recruiting nowThis study tests a combination of chemotherapy drugs (carboplatin or cisplatin, paclitaxel) and an immunotherapy drug (toripalimab) in adults with advanced throat cancer that has come back or spread. The goal is to see if this treatment can control the cancer and help patients av…
Matched conditions: LOCALLY ADVANCED LARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated May 18, 2026 12:02 UTC